Literature DB >> 24096257

Prevalence of arterial hypertension in Serbia: PAHIS study.

Dragan Lovic1, Vesna Stojanov, Branko Jakovljević, Mirjana Krotin, Vladimir Jurisic, Dragan Djordjevic, Katarina Paunović, Marija Zdravkovic, Dejan Simonovic, Dusan Bastac, Banko Lovic.   

Abstract

BACKGROUND: Arterial hypertension (AH) is the most common cardiovascular disease risk factor, affecting between 30 and 50% of the adult population in developed countries. A steady increase of the prevalence of AH by about 60% is expected by year 2025.
METHODS: Serbian Society of Hypertension conducted a prevalence study from February to May 2012 on a sample of 3878 adult respondents. The study included 2066 women (53.3%) and 1812 men (46.7%). Average age was 48.89 ± 17.48 years. Most participants resided in urban areas (2956 people, 76.2%), whereas 922 resided in rural areas (23.8%).
RESULTS: The prevalence of AH in Serbia is 42.7%. Hypertension is more frequently diagnosed among women (53.3%), than among men (46.7%). One thousand, four hundred and twelve respondents were previously diagnosed and treated for hypertension. The estimated awareness of the presence of AH was 42.99% (i.e. 40.00% among male and 45.41% among female participants). Out of all diagnosed cases of hypertension, 390 persons (27.7%) have well regulated blood pressure values, whereas 1022 persons (72.3%) do not have their blood pressure under control.
CONCLUSION: Serbia belongs to countries with a high prevalence of AH. A poor control of AH may be explained in view of socioeconomic problems. High prevalence of AH may indicate a remarkably high cardiovascular disease mortality in Serbia.

Entities:  

Mesh:

Year:  2013        PMID: 24096257     DOI: 10.1097/HJH.0b013e328364c2a2

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Improving Blood Pressure Control Using Digital Communication Methods in Serbia.

Authors:  Nebojsa Tasic; Danijela Tasic; Zorana Kovacevic; Marko Filipovic; Milan Arsic; Sladjana Bozovic-Ogarevic; Biljana Despotovic; Milovan Bojic; Zlatko Maksimovic; Nebojsa Zdravkovic; Sara Mijailovic; Vladimir Zivkovic; Tamara Nikolic Turnic; Vladimir Jakovljevic
Journal:  Diagnostics (Basel)       Date:  2022-04-06

Review 2.  Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update.

Authors:  Renata Cifkova; George Fodor; Peter Wohlfahrt
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

3.  Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.

Authors:  Dragan B Djordjevic; Ivan S Tasic; Svetlana T Kostic; Bojana N Stamenkovic; Milan B Lovic; Nikola D Djordjevic; Goran P Koracevic; Dragan B Lovic
Journal:  Clin Cardiol       Date:  2020-06-03       Impact factor: 2.882

4.  A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction.

Authors:  Hao Li; Yuan Cui; Jin Tian; Hong Yang; Qing Zhang; Ke Wang; Qinghua Han; Yanbo Zhang
Journal:  Open Med (Wars)       Date:  2020-07-10

5.  Body Composition Indices and Cardiovascular Risk in Type 2 Diabetes. CV Biomarkers are not Related to Body Composition.

Authors:  Aleksandra Markova; Mihail Boyanov; Deniz Bakalov; Adelina Tsakova
Journal:  Open Med (Wars)       Date:  2020-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.